Analyst Ratings February 10, 2026

DA Davidson Cuts Dynatrace Price Target to $50, Keeps Buy Rating After Strong ARR and Revenue Results

Analyst trims valuation while praising market-share gains and pipeline expansion amid solid ARR growth

By Maya Rios DT
DA Davidson Cuts Dynatrace Price Target to $50, Keeps Buy Rating After Strong ARR and Revenue Results
DT

DA Davidson reduced its 12-month price target for Dynatrace Inc. to $50 from $65 but retained a Buy rating after the company reported quarterly results that featured stronger-than-expected net new annual recurring revenue (ARR) and continued revenue acceleration. Dynatrace posted 18.2% year-over-year revenue growth and sustained an 81.75% gross profit margin, with management raising its growth outlook and the company gaining traction in log management and end-to-end observability deals.

Key Points

  • DA Davidson cut its Dynatrace price target to $50 from $65 but maintained a Buy rating; the target remains above the current share price of $36.76.
  • Dynatrace reported stronger-than-expected net new ARR, 18.2% year-over-year revenue growth, and an 81.75% gross profit margin, with management lifting its growth outlook.
  • Several other brokerages adjusted their targets and ratings — Truist ($55 Buy), KeyBanc ($52), Scotiabank ($47), Stifel ($51), and BMO Capital ($45) — reflecting divergent views on valuation despite solid ARR performance.

What happened

DA Davidson on Tuesday lowered its price target on Dynatrace Inc. (NYSE:DT) to $50.00 from $65.00, while leaving its Buy rating intact. The updated target remains above Dynatrace's most recent share price of $36.76 and well below the stock's 52-week high of $63.

Quarterly drivers

The research firm cited the company’s latest quarterly report, which produced stronger-than-expected net new ARR, attributing the boost to end-to-end observability contracts. Dynatrace reported revenue growth of 18.2% year-over-year and sustained a gross profit margin of 81.75%, metrics DA Davidson highlighted in its rationale for keeping a positive stance on the stock.

Market positioning and sales dynamics

DA Davidson noted that Dynatrace is continuing to take share in the market, singling out its log management product as a particular area of traction. The firm also pointed to recent go-to-market changes that have resulted in what it described as "impressive pipeline growth," and stated that the company "remains well positioned as a longterm winner in observability."

Peer and analyst context

Other analysts have varied views on Dynatrace’s near-term valuation even as many acknowledge healthy ARR trends. Truist Securities reiterated a Buy rating with a $55 price target. KeyBanc increased its target to $52 from $50, citing a strong third-quarter performance that exceeded its estimates. Scotiabank trimmed its target to $47 from $60, while Stifel lowered its target to $51 from $63 but kept a Buy rating, noting record new logo ARR growth of 21% year-over-year. BMO Capital reduced its price target to $45 from $56, referencing valuation compression while acknowledging the company’s positive performance and an increase in ARR guidance.

Business description

Dynatrace provides software intelligence platforms designed to help organizations monitor and optimize application performance, IT infrastructure, and user experience across cloud environments.

Takeaway

DA Davidson’s decision to lower its price target yet preserve a Buy rating reflects a balance between valuation caution and continued confidence in Dynatrace’s growth trajectory and market position. Analysts across the sell side show divergent target adjustments even as the company posts stable ARR growth and nudges up its growth outlook for the year.

Risks

  • Valuation compression cited by at least one analyst - this could affect investor sentiment and share price despite revenue and ARR strength.
  • Divergent analyst price-target changes indicate uncertainty among sell-side firms about the appropriate valuation multiple, which may translate into short-term stock volatility.
  • Performance remains linked to continued ARR expansion and successful execution of go-to-market changes; any slowdown in net new ARR or pipeline conversion could alter analyst outlooks.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026